Search research articles
Contact Us
Filters
Showing results (151-160 of 277) with videos related to
Page
of 28
Sort By:
Breast Cancer Research : BCR
|
August 20, 2020
Clinical implications of prospective genomic profiling of metastatic breast cancer patients
Courtney T van Geelen, Peter Savas, Zhi Ling Teo, et al.
Breast Cancer Research : BCR
|
July 15, 2022
Correction to: Clinical implications of prospective genomic profiling of metastatic breast cancer patients
Courtney T van Geelen, Peter Savas, Zhi Ling Teo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 2013
Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98
Sherene Loi, Nicolas Sirtaine, Fanny Piette, et al.
ESMO Open
|
August 11, 2018
Multidisciplinary molecular tumour board: a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer
Christian Rolfo, Paolo Manca, Roberto Salgado, et al.
Research Square
|
May 25, 2026
QuTILs: Open-Source Image-Based Infiltrating Immune Cell Detection for Research Application
Mark Vater, Roberto Salgado, Elijah Blige, et al.
Journal of Medical Imaging (Bellingham, Wash.)
|
August 1, 2022
Pilot study to evaluate tools to collect pathologist annotations for validating machine learning algorithms
Katherine Elfer, Sarah Dudgeon, Victor Garcia, et al.
The Lancet. Oncology
|
October 1, 2020
Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial
Leisha A Emens, Francisco J Esteva, Mark Beresford, et al.
International Journal of Cancer
|
January 7, 2020
Reactive stroma and trastuzumab resistance in HER2-positive early breast cancer
Amir Sonnenblick, Mali Salmon-Divon, Roberto Salgado, et al.
Cell Reports
|
October 7, 2015
Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome
Debora Fumagalli, David Gacquer, Françoise Rothé, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 25, 2024
Empowering effective biomarker-driven precision oncology: A call to action
Mark Lawler, Peter Keeling, Olga Kholmanskikh, et al.
Page
of 28
Search research articles
Search
Showing results (151-160 of 277) with videos related to
Sort By:
Page
of 28
Breast Cancer Research : BCR
|
August 20, 2020
Clinical implications of prospective genomic profiling of metastatic breast cancer patients
Courtney T van Geelen, Peter Savas, Zhi Ling Teo, et al.
Breast Cancer Research : BCR
|
July 15, 2022
Correction to: Clinical implications of prospective genomic profiling of metastatic breast cancer patients
Courtney T van Geelen, Peter Savas, Zhi Ling Teo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 2013
Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98
Sherene Loi, Nicolas Sirtaine, Fanny Piette, et al.
ESMO Open
|
August 11, 2018
Multidisciplinary molecular tumour board: a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer
Christian Rolfo, Paolo Manca, Roberto Salgado, et al.
Research Square
|
May 25, 2026
QuTILs: Open-Source Image-Based Infiltrating Immune Cell Detection for Research Application
Mark Vater, Roberto Salgado, Elijah Blige, et al.
Journal of Medical Imaging (Bellingham, Wash.)
|
August 1, 2022
Pilot study to evaluate tools to collect pathologist annotations for validating machine learning algorithms
Katherine Elfer, Sarah Dudgeon, Victor Garcia, et al.
The Lancet. Oncology
|
October 1, 2020
Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial
Leisha A Emens, Francisco J Esteva, Mark Beresford, et al.
International Journal of Cancer
|
January 7, 2020
Reactive stroma and trastuzumab resistance in HER2-positive early breast cancer
Amir Sonnenblick, Mali Salmon-Divon, Roberto Salgado, et al.
Cell Reports
|
October 7, 2015
Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome
Debora Fumagalli, David Gacquer, Françoise Rothé, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 25, 2024
Empowering effective biomarker-driven precision oncology: A call to action
Mark Lawler, Peter Keeling, Olga Kholmanskikh, et al.
Page
of 28